Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($) $ in Thousands	Total	Initial Public Offering	Common Stock	Common Stock Initial Public Offering	Additional Paid-in Capital	Additional Paid-in Capital Initial Public Offering	Accumulated Deficit
Beginning Balance at Dec. 31, 2020	$ (2,773)				$ 3		$ (2,776)
Beginning Balance, Shares at Dec. 31, 2020			4,759,968
Issuance of common stock, Shares			1,606,815
Vesting restrictions placed on previously issued and outstanding common stock	(1)				(1)
Vesting restrictions placed on previously issued and outstanding common stock, Shares			(2,332,386)
Vesting of restricted shares	1				1
Vesting of restricted shares, Shares			971,824
Net loss	(3,213)						(3,213)
Ending Balance at Jun. 30, 2021	(5,986)				3		(5,989)
Ending Balance, Shares at Jun. 30, 2021			5,006,221
Beginning Balance at Mar. 31, 2021	(4,320)				2		(4,322)
Beginning Balance, Shares at Mar. 31, 2021			4,860,449
Vesting of restricted shares	1				1
Vesting of restricted shares, Shares			145,772
Net loss	(1,667)						(1,667)
Ending Balance at Jun. 30, 2021	(5,986)				3		(5,989)
Ending Balance, Shares at Jun. 30, 2021			5,006,221
Beginning Balance at Dec. 31, 2021	(100,757)		$ 1		4,426		(105,184)
Beginning Balance, Shares at Dec. 31, 2021			6,599,886
Issuance of common stock		$ 209,515		$ 1		$ 209,514
Issuance of common stock, Shares				13,529,750
Conversion of August 2021 Notes and accrued interest into common shares	215,364		$ 1		215,363
Conversion of August 2021 Notes and accrued interest into common shares, Shares			10,672,138
Conversion of Takeda Warrant liability into equity	100,020				100,020
Vesting of restricted shares, Shares			509,613
Stock - based compensation	828				828
Net loss	(121,816)						(121,816)
Ending Balance at Jun. 30, 2022	303,154		$ 3		530,151		(227,000)
Ending Balance, Shares at Jun. 30, 2022			31,311,387
Beginning Balance at Mar. 31, 2022	(168,372)		$ 1		4,698		(173,071)
Beginning Balance, Shares at Mar. 31, 2022			6,897,450
Issuance of common stock		$ 209,515		$ 1		$ 209,514
Issuance of common stock, Shares				13,529,750
Conversion of August 2021 Notes and accrued interest into common shares	215,364		$ 1		215,363
Conversion of August 2021 Notes and accrued interest into common shares, Shares			10,672,138
Conversion of Takeda Warrant liability into equity	100,020				100,020
Vesting of restricted shares, Shares			212,049
Stock - based compensation	556				556
Net loss	(53,929)						(53,929)
Ending Balance at Jun. 30, 2022	$ 303,154		$ 3		$ 530,151		$ (227,000)
Ending Balance, Shares at Jun. 30, 2022			31,311,387